Literature DB >> 17351337

Interfering with MAP kinase docking interactions: implications and perspective for the p38 route.

Federico Mayor1, Maria Jurado-Pueyo, Pedro M Campos, Cristina Murga.   

Abstract

Docking interactions are key to understand the dynamic assembly of signal transduction complexes in the cell. In particular, the docking domain (D domain)-dependent interactions described so far for several MAPK routes are essential to specify the upstream regulators, downstream mediators and also inactivators that complex with the p38, JNK and ERK proteins. In addition to contributing to the maintenance of the linearity and specificity of these pathways, novel data have revealed that docking contacts also regulate the activity, subcellular distribution and substrate selection of each MAPK. Moreover, phosphorylation inside or around a docking domain is emerging as a novel mechanism of regulation of MAPK association with cellular partners, suggesting new potential strategies for the design of selective MAPK inhibitors. Here, we discuss these novel data and the biochemical and cellular implications they may have with specific emphasis on the p38 route.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351337     DOI: 10.4161/cc.6.5.3920

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  23 in total

1.  Phosphorylation of ORF1p is required for L1 retrotransposition.

Authors:  Pamela R Cook; Charles E Jones; Anthony V Furano
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 2.  Unique MAP Kinase binding sites.

Authors:  Radha Akella; Thomas M Moon; Elizabeth J Goldsmith
Journal:  Biochim Biophys Acta       Date:  2007-11-19

3.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

4.  Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.

Authors:  Juan Wang; Jun-Ying Zhou; Lianfeng Zhang; Gen Sheng Wu
Journal:  Cell Cycle       Date:  2009-10-07       Impact factor: 4.534

5.  Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats.

Authors:  Shobha Bhaskar; A Helen
Journal:  Mol Cell Biochem       Date:  2016-09-24       Impact factor: 3.396

6.  A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.

Authors:  Jing Li; Tamer S Kaoud; Jake LeVieux; Brad Gilbreath; Swapna Moharana; Kevin N Dalby; Sean M Kerwin
Journal:  Chembiochem       Date:  2012-12-06       Impact factor: 3.164

7.  Protective effects of edaravone on diffuse brain injury in rats.

Authors:  Jian-Min Li; Pan Zhang; Ya-Ning Zhao; Chang-Xiang Chen; Shu-Xing Li
Journal:  World J Emerg Med       Date:  2011

8.  p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses.

Authors:  J Jefferson P Perry; Rodney M Harris; Davide Moiani; Arthur J Olson; John A Tainer
Journal:  J Mol Biol       Date:  2009-06-06       Impact factor: 5.469

9.  MAPK pathway activation delays G2/M progression by destabilizing Cdc25B.

Authors:  Puji Astuti; Tanya Pike; Charlotte Widberg; Elizabeth Payne; Angus Harding; John Hancock; Brian Gabrielli
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

10.  Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1).

Authors:  Rosalia Dettori; Silvina Sonzogni; Lucas Meyer; Laura A Lopez-Garcia; Nick A Morrice; Stefan Zeuzem; Matthias Engel; Albrecht Piiper; Sonja Neimanis; Morten Frödin; Ricardo M Biondi
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.